← Leaderboards
Alan Mendelowitz
Long Island Jewish Medical Center
$2,400,912
Attributed
$2,400,912
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $561.2K · FY2006–10$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,400,912 · 5
By mechanism
U01$1,296,338 · 1
M01$578,929 · 3
P30$525,645 · 1
Top collaborators
No co-investigators on record.
Most similar at Long Island Jewish Medical Center
Same institution · by research overlap
- Anil K Malhotra$14,850,627
- John M Kane$49,583,682
- Delbert G Robinson$11,665,634
- Judith Jaeger$4,274,162
- Joseph C Blader$5,147,981
Others in their field
Top investigators on “Antipsychotic Agents”
- P Jeffrey Conn · Vanderbilt University$24,634,463
- Abraham Aizer Brody · New York University School Of Medicine$22,358,187
- Constantine G Lyketsos · Johns Hopkins University$14,554,427
- John H Krystal · Yale University$14,263,729
- Dilip V Jeste · University Of California San Diego$13,885,388
- Thomas Scott Stroup · University Of North Carolina Chapel Hill$12,935,020
Research focus
Antipsychotic AgentsSchizophreniaClinical ResearchPharmaceutical PreparationsBlindInjectableGenerationsRandomizedAtypical AntipsychoticMicrospheresOralRisperidoneAdverse EffectsInnovationAccident And Emergency DepartmentHealth BenefitHospitalsMasksCholesterolDiscontinuation TrialDesignDisorder Later Incidence PreventionBed OccupancyDay Care
Grant awards (11)
CLINICAL TRIAL: RELAPSE PREVENTION: LONG-ACTING ATYPICAL ANTIPSYCHOTICS$321,758
M01 · FY2010 · RR · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$239,486
U01 · FY2010 · MH · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$276,390
U01 · FY2009 · MH · contact PI
CLINICAL TRIAL: RELAPSE PREVENTION: LONG-ACTING ATYPICAL ANTIPSYCHOTICS$86,824
M01 · FY2009 · RR · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$270,935
U01 · FY2008 · MH · contact PI
CLINICAL TRIAL: RELAPSE PREVENTION: LONG-ACTING ATYPICAL ANTIPSYCHOTICS$170,347
M01 · FY2008 · RR · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$259,083
U01 · FY2007 · MH · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$250,444
U01 · FY2006 · MH · contact PI
CORE--KNOWLEDGE TRANSFER$175,215
P30 · FY2002 · MH
CORE--KNOWLEDGE TRANSFER$175,215
P30 · FY2001 · MH
CORE--KNOWLEDGE TRANSFER$175,215
P30 · FY2000 · MH